Dr Komrokji explains how the IPSS-M improves prognostic precision in MDS but cautions that upstaging alone should not ...

Published on April 01, 2026, in Volume 2, article number 19 of the journal Immunity & Inflammation , a collaborative team led by Prof. Cao at the ...

Myelodysplastic syndromes (MDS) are malignant disorders arising from hematopoietic stem cells, yet the precise epigenetic abnormalities occurring in the primitive stem cells remain poorly understood.

BMY stock jumps 10% in a month as growth drugs power revenues, but generic erosion and 2026 sales outlook keep investors ...

GAITHERSBURG, Md., April 08, 2026 (GLOBE NEWSWIRE) -- Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in ...

Study from Japan shows near-tripling over 30-year period ...

Internationally Renowned Cancer and Stem Cell Researcher to Lead Bronx-Based NCI-Designated Center ...

Published on April 01, 2026, in Volume 2, article number 19 of the journal Immunity & Inflammation, a collaborative team led ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced the publication of two abstracts that will be ...

Rigel Pharmaceuticals' Gavreto acquisition materially boosted revenue and is valued at ~$245M NPV, about half of RIGL's ...

Some studies have found increased risks for skin cancers and hematologic malignancies in people with tattoos; others found no ...

SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced that the Company will present at the 25 th Annual Needham Virtual Healthcare Conference being held April ...